CHEMODNERVATION FOR CERVICAL DYSTONIA: A CLINICAL REVIEW

被引:1
|
作者
Ameer, Muhammad Atif [1 ]
Bhatti, Danish [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Neurol Sci, Omaha, NE 68198 USA
来源
KHYBER MEDICAL UNIVERSITY JOURNAL-KMUJ | 2020年 / 12卷 / 03期
关键词
Cervical Dystonia; Torticollis; Chemodenervation; Nerve Block; Botulinum Toxins; Movement Disorders; BOTULINUM TOXIN INJECTION; SPASMODIC TORTICOLLIS; DOUBLE-BLIND; AMERICAN-ACADEMY; NEUROTOXIN; EFFICACY; LONG; SAFETY; MANAGEMENT; TETANUS;
D O I
10.35845/kmuj.2020.20478
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cervical dystonia (CD) is a focal dystonia characterized by involuntary contractions of neck muscles that result in patterned movements and abnormal postures of the head and neck that have a directional quality. CD is the most common form of dystonia presenting to the movement disorders clinic. Botulinum toxin is an effective treatment for cervical dystonia. It has become the first-line treatment for cervical dystonia with a satisfactory relief of symptoms reported in more than 80% of the cases. Multiple small and large scale studies proven that fact and provided Class-A evidence for the benefit. However, 20% of the patients discontinue treatment due to adverse effects, treatment failure and other reasons. With the proper knowledge of toxins and the anatomy of the neck, much better results can be achieved with fewer and self-limiting adverse effects as compared to other modalities. However, the expert consensus recommendations are lacking to guide clinicians for optimal use of botulinum toxin for cervical dystonias. This paper discusses the different available treatments, botulinum injection techniques and the adverse effects involved with the procedure.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 50 条
  • [1] Treatment of cervical dystonia
    Brashear, Allison
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (08): : 599 - 606
  • [2] Duration of botulinum toxin efficacy in cervical dystonia clinical trials: A scoping review
    Castagna, Anna
    Jinnah, Hyder A.
    Albanese, Alberto
    PARKINSONISM & RELATED DISORDERS, 2024, 125
  • [3] Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia
    Marsh, Wallace A.
    Monroe, Deirdre M.
    Brin, Mitchell F.
    Gallagher, Conor J.
    BMC NEUROLOGY, 2014, 14
  • [4] Long-Term Abobotulinumtoxin A Treatment of Cervical Dystonia
    Bentivoglio, A. R.
    Di Stasio, E.
    Mulas, D.
    Cerbarano, M. L.
    Ialongo, T.
    Laurienzo, A.
    Petracca, Martina
    NEUROTOXICITY RESEARCH, 2017, 32 (02) : 291 - 300
  • [5] Clinical Characteristics and Response to Long-Term Botulinum Toxin Type A Therapy in Patients with Cervical Dystonia at a Neurology Clinic
    Sen, Aysu
    Soysal, Aysun
    Arpaci, Baki
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2014, 51 (04): : 383 - 388
  • [6] Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice
    Trosch, Richard M.
    Misra, Vijay P.
    Maisonobe, Pascal
    Om, Savary
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2020, 3
  • [7] Use of AbobotulinumtoxinA in Adults with Cervical Dystonia: A Systematic Literature Review
    Fasano, Alfonso
    Paramanandam, Vijayashankar
    Jog, Mandar
    TOXINS, 2020, 12 (08)
  • [8] Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A
    Mills, Reversa R.
    Pagan, Fernando L.
    PATIENT PREFERENCE AND ADHERENCE, 2015, 9 : 725 - 731
  • [9] Eligibility criteria in clinical trials for cervical dystonia
    Vergallo, Andrea
    Cocco, Antoniangela
    De Santis, Tiziana
    Lalli, Stefania
    Albanese, Alberto
    PARKINSONISM & RELATED DISORDERS, 2022, 104 : 110 - 114
  • [10] Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance
    Samotus, Olivia
    Lee, Jack
    Jog, Mandar
    JOURNAL OF NEUROLOGY, 2018, 265 (06) : 1269 - 1278